Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Additionally, Sikiric is listed online as the CEO of a company called Diagen, which says it owns a patent for a special stable version of BPC-157
For context, purchasing BPC-157, TB-500, GHK-Cu, and KPV individually through separate prescriptions would typically cost significantly more per month, plus you would need to manage four separate products, dosing schedules, and injection protocols
Legal Status of DSIP DSIP, like many experimental peptides, sits in a regulatory gray zone
The Journal of Biological Chemistry 279: 2624326250
US$ 24.74
US$ 26.41
US$ 20.45
